Semanteon Capital Management, LP Evolus, Inc. Transaction History
Semanteon Capital Management, LP
- $147 Billion
- Q3 2024
A detailed history of Semanteon Capital Management, LP transactions in Evolus, Inc. stock. As of the latest transaction made, Semanteon Capital Management, LP holds 56,313 shares of EOLS stock, worth $916,212. This represents 0.62% of its overall portfolio holdings.
Number of Shares
56,313Holding current value
$916,212% of portfolio
0.62%Shares
3 transactions
Others Institutions Holding EOLS
# of Institutions
164Shares Held
49.3MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$93.6 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$78.9 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$65.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$48.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$47.4 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $913M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...